Abstract
Comparative molecular field analysis (CoMFA) studies were conducted on a series of 100 isoniazid derivatives as anti-tuberculosis agents using two receptor-independent structural data set alignment strategies: (1) rigid-body fit, and (2) pharmacophore-based. Significant cross-validated correlation coefficients were obtained (CoMFA(1), q2 =0,75 and CoMFA(2), q2 = 0.74), indicating the potential of the models for untested compounds. The models were then used to predict the inhibitory potency of 20 test set compounds that were not included in the training set, and the predicted values were in good agreement with the experimental results.
Keywords: Tuberculosis, Hydrazides, Drug design, QSAR, CoMFA, Galahad
Letters in Drug Design & Discovery
Title: Three-Dimensional Quantitative Structure-Activity Relationships for a Large Series of Potent Antitubercular Agents
Volume: 5 Issue: 6
Author(s): Carolina Horta Andrade, Livia de Barros Salum, Kerly Fernanda Mesquita Pasqualoto, Elizabeth Igne Ferreira and Adriano Defini Andricopulo
Affiliation:
Keywords: Tuberculosis, Hydrazides, Drug design, QSAR, CoMFA, Galahad
Abstract: Comparative molecular field analysis (CoMFA) studies were conducted on a series of 100 isoniazid derivatives as anti-tuberculosis agents using two receptor-independent structural data set alignment strategies: (1) rigid-body fit, and (2) pharmacophore-based. Significant cross-validated correlation coefficients were obtained (CoMFA(1), q2 =0,75 and CoMFA(2), q2 = 0.74), indicating the potential of the models for untested compounds. The models were then used to predict the inhibitory potency of 20 test set compounds that were not included in the training set, and the predicted values were in good agreement with the experimental results.
Export Options
About this article
Cite this article as:
Andrade Horta Carolina, Salum de Barros Livia, Mesquita Pasqualoto Fernanda Kerly, Ferreira Igne Elizabeth and Andricopulo Defini Adriano, Three-Dimensional Quantitative Structure-Activity Relationships for a Large Series of Potent Antitubercular Agents, Letters in Drug Design & Discovery 2008; 5 (6) . https://dx.doi.org/10.2174/157018008785777289
DOI https://dx.doi.org/10.2174/157018008785777289 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Formulation of Rifampicin Loaded PEGylated 5.0G EDA-PAMAM Dendrimers as Effective Long-Duration Release Drug Carriers
Current Drug Therapy Immunosuppressant Drugs and Covid-19: Associated Risks, Drug-Drug Interactions and Contraindications
Coronaviruses Synthesis, Antimycobacterial Activities and Phototoxic Evaluation of 5H-thiazolo[3,2-a]quinoline-4-carboxylic Acid Derivatives
Medicinal Chemistry Exploring Coumarin and Chalcone Analogues as Potential Antimycobacterial Agents
Anti-Infective Agents Carbonic Anhydrases An Overview
Current Pharmaceutical Design Design of multifunctional nanocarriers for delivery of anti-cancer therapy
Current Pharmaceutical Design Proteomic Study of the Mechanism of Talin-C as an Inhibitor of HIV Infection
Current Proteomics Homology Models in Docking and High-Throughput Docking
Current Topics in Medicinal Chemistry Synthesis and SAR Studies of Urea and Thiourea Derivatives of Gly/Pro Conjugated to Piperazine Analogue as Potential AGE Inhibitors
Protein & Peptide Letters Specific Targeting of Engineered Nanoparticles to Activated Macrophages
Current Nanoscience Short-Term Transfer of Knowledge Assessment in the Military International HIV Training Program (MIHTP)
Current HIV Research Structure-based Discovery of Narirutin as a Shikimate kinase Inhibitor with Anti-tubercular Potency
Current Computer-Aided Drug Design Adenylating Enzymes in Mycobacterium tuberculosis as Drug Targets
Current Topics in Medicinal Chemistry Recent Advancement in the Diagnosis and Treatment of Leprosy
Current Topics in Medicinal Chemistry Penicillium marneffei and its Pulmonary Involvements
Current Respiratory Medicine Reviews Should We Develop an Inhaled Anti-pneumococcal Vaccine for Adults?
Current Medicinal Chemistry - Anti-Infective Agents Multi-Drug Resistant Pulmonary Tuberculosis
Current Respiratory Medicine Reviews Angiogenic and Antiangiogenic Factors in Proliferative Diabetic Retinopathy
Current Diabetes Reviews Resistant Tuberculosis: the Latest Advancements of Second-line Antibiotic Inhalation Products
Current Pharmaceutical Design Design, Synthesis and In Vitro Biological Evaluation of Pyridine, Thiadazole, Benzimidazole and Acetyl Thiophene Analogues as Anti Tubercular Agents Targeting Enzyme Inh A
Current Computer-Aided Drug Design